Looking at SBBP press release. Presentation coming Monday, March 13, 1230pm PT. Increased on Friday going into weekend. Watch going into the weekend before March 13th. Legs?
Strongbridge's first commercial product is KEVEYIS® (dichlorphenamide), the first and only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis. KEVEYIS has orphan drug exclusivity status in the U.S. through August 7, 2022.
Looking at ONCS gaining at market close. Looking for Monday morning spike?
Posted Mar 04, 17 12:59 PMbyRickEzekiel
Received 1 Karma
Based on a quick look at ONCS it looks like it doesn't hold it's spikes although it does spike. I would say it's a wait and see more than an expectation.
Great! Thanks for the feedback.
what do you use for paper trading?
Nope.
Join now or log in to leave a comment